As of 2025-10-29, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 27.85 USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.62 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 23.1%.
The range of the Relative Valuation is 20.96 - 34.28 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 17.8x | 17.2x |
| Forward P/E multiples | 16.2x - 19.9x | 19.2x |
| Fair Price | 20.96 - 34.28 | 27.85 |
| Upside | -7.3% - 51.6% | 23.1% |
| Date | P/E |
| 2025-10-28 | 17.18 |
| 2025-10-27 | 17.46 |
| 2025-10-24 | 16.72 |
| 2025-10-23 | 16.50 |
| 2025-10-22 | 16.24 |
| 2025-10-21 | 16.15 |
| 2025-10-20 | 15.90 |
| 2025-10-17 | 15.86 |
| 2025-10-16 | 15.66 |
| 2025-10-15 | 16.51 |
| 2025-10-14 | 15.46 |
| 2025-10-13 | 15.23 |
| 2025-10-10 | 15.23 |
| 2025-10-09 | 15.67 |
| 2025-10-08 | 16.18 |
| 2025-10-07 | 16.36 |
| 2025-10-06 | 16.40 |
| 2025-10-03 | 16.56 |
| 2025-10-02 | 16.24 |
| 2025-10-01 | 16.13 |
| 2025-09-30 | 16.21 |
| 2025-09-29 | 16.19 |
| 2025-09-26 | 15.99 |
| 2025-09-25 | 16.11 |
| 2025-09-24 | 16.15 |
| 2025-09-23 | 17.92 |
| 2025-09-22 | 18.63 |
| 2025-09-19 | 18.54 |
| 2025-09-18 | 18.80 |
| 2025-09-17 | 18.38 |
| 2025-09-16 | 18.20 |
| 2025-09-15 | 18.73 |
| 2025-09-12 | 17.93 |
| 2025-09-11 | 18.38 |
| 2025-09-10 | 18.07 |
| 2025-09-09 | 18.86 |
| 2025-09-08 | 19.28 |
| 2025-09-05 | 19.18 |
| 2025-09-04 | 19.36 |
| 2025-09-03 | 19.53 |
| 2025-09-02 | 19.51 |
| 2025-08-29 | 19.74 |
| 2025-08-28 | 19.92 |
| 2025-08-27 | 20.18 |
| 2025-08-26 | 19.53 |
| 2025-08-25 | 19.23 |
| 2025-08-22 | 19.55 |
| 2025-08-21 | 18.82 |
| 2025-08-20 | 18.94 |
| 2025-08-19 | 18.96 |